---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-088426"
form_type: "8-K"
ticker: "EWTX"
cik: "0001710072"
company_name: "Edgewise Therapeutics, Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:04:51.718284+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Edgewise Therapeutics adopts 2024 Inducement Plan, reserving 2M shares for new hires

## Summary
- Board adopted 2024 Inducement Equity Incentive Plan effective August 10, 2024, reserving 2,000,000 shares of common stock.
- Plan allows grants of nonstatutory stock options, SARs, restricted stock, RSUs, and performance awards as hiring inducements.
- Adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4) – limited to new employees or merger hires.
- Terms are substantially similar to the 2021 Equity Incentive Plan; no Exchange Program is permitted.

## SEC filing metadata
- accession: 0001104659-24-088426
- form_type: 8-K
- ticker: EWTX
- cik: 0001710072
- company_name: Edgewise Therapeutics, Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710072/000110465924088426/0001104659-24-088426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710072/000110465924088426/tm2421320d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-088426
- JSON: https://secwatch.observer/filing/0001104659-24-088426.json
- Plain text: https://secwatch.observer/filing/0001104659-24-088426.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.